Cipla Shares Gain After Acquisition Of Anti-Infective Drug Elores

Shares of Cipla gained a percent intraday on October 18 after acquisition of anti-infective drug Elores from Venus Remedies.

The drug maker announced the acquisition of a novel and patented anti-infective product for the Indian market to further strengthen its presence in the branded Indian critical care space and as a part of its agenda to contribute to the fight against Anti-Microbial Resistance.

For more information ✆ +91- 6232578593 or visit www.moneymarketmanthan.com